Srividhya Senthil

Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Targeting the cytokine storm: new therapies in the treatment of paediatric haemophagocytic lymphohistiocytosis.

Targeting the cytokine storm: new therapies in the treatment of paediatric haemophagocytic lymphohistiocytosis.

Journal: Expert review of clinical immunology
Published: June 18, 2026

Targeting the cytokine storm: new therapies in the treatment of pediatric hemophagocytic lymphohistiocytosis.

Targeting the cytokine storm: new therapies in the treatment of pediatric hemophagocytic lymphohistiocytosis.

Journal: Expert review of clinical immunology
Published: June 18, 2026

Case Report: Haemopoietic stem cell transplantation in refractory paediatric RAS-associated lymphoproliferative disorder.

Case Report: Haemopoietic stem cell transplantation in refractory paediatric RAS-associated lymphoproliferative disorder.

Journal: Frontiers in immunology
Published: April 08, 2026

Acyclovir-Resistant Herpes Simplex Virus in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant: A Case Series.

Acyclovir-Resistant Herpes Simplex Virus in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant: A Case Series.

Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: October 02, 2025

Farber's Lipogranulomatosis: Multimodal Therapy With Tocilizumab and Consolidative HSCT Improves Assessment, and Long-Term Outcome.

Farber's Lipogranulomatosis: Multimodal Therapy With Tocilizumab and Consolidative HSCT Improves Assessment, and Long-Term Outcome.

Journal: JIMD reports
Published: June 02, 2025

Utility and Safety of Romiplostim in Pediatric Allogeneic Stem Cell Transplantation.

Utility and Safety of Romiplostim in Pediatric Allogeneic Stem Cell Transplantation.

Journal: Pediatric transplantation
Published: May 13, 2025

Donor T-cell and myeloid chimerism is higher after cord blood transplant than with other cell sources.

Donor T-cell and myeloid chimerism is higher after cord blood transplant than with other cell sources.

Journal: Cytotherapy
Published: April 26, 2025

Thrombolysis for superior vena cava syndrome post bone marrow transplant: a paediatric experience.

Thrombolysis for superior vena cava syndrome post bone marrow transplant: a paediatric experience.

Journal: BMJ case reports
Published: March 19, 2025

Impact of shared HLA determinants between patient and losing cord blood unit on relapse after double cord blood transplantation.

Impact of shared HLA determinants between patient and losing cord blood unit on relapse after double cord blood transplantation.

Journal: Blood advances
Published: January 17, 2025

Mixed T-Cell Chimerism Following Hematopoietic Cell Transplantation for Non-Malignant Disorders Is Common, Facilitates Anti-Viral Immunity, and Is Not Associated with Graft Failure in Pediatric Patients.

Mixed T-Cell Chimerism Following Hematopoietic Cell Transplantation for Non-Malignant Disorders Is Common, Facilitates Anti-Viral Immunity, and Is Not Associated with Graft Failure in Pediatric Patients.

Journal: Cells
Published: October 20, 2024

Granulocyte transfusion during cord blood transplant for relapsed, refractory AML is associated with massive CD8+ T-cell expansion, significant cytokine release syndrome and induction of disease remission.

Granulocyte transfusion during cord blood transplant for relapsed, refractory AML is associated with massive CD8+ T-cell expansion, significant cytokine release syndrome and induction of disease remission.

Journal: British journal of haematology
Published: February 16, 2023

Wiskott Aldrich Syndrome-2 Caused by Novel Wiskott Aldrich Syndrome Protein-Interacting Protein (WIP) Deficiency Is Associated with Juvenile Myelomonocytic Leukaemia - a Case Report.

Wiskott Aldrich Syndrome-2 Caused by Novel Wiskott Aldrich Syndrome Protein-Interacting Protein (WIP) Deficiency Is Associated with Juvenile Myelomonocytic Leukaemia - a Case Report.

Journal: Journal of clinical immunology
Published: June 03, 2022
Showing 1-12 of 13

Last Updated: 09/26/2026